Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: Japan Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20111
20142
20153
20164
20171
20182
20201
20221
20231
20247
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting7
Active, not recruiting6
Terminated6
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Eli Lilly and Company5
Novartis Pharmaceuticals4
AstraZeneca2
Boehringer Ingelheim2
EMD Serono Research & Development Institute, Inc.2
Mie University2
Alterome Therapeutics, Inc.1
Astellas Pharma Global Development, Inc.1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms29
Carcinoma, Non-Small-Cell Lung11
Triple Negative Breast Neoplasms10
Esophageal Neoplasms9
Breast Neoplasms8
Squamous Cell Carcinoma of Head and Neck8
Melanoma7
Endometrial Neoplasms6
Neoplasms6
Stomach Neoplasms6

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.